Cargando…

Selenium Treatment and Chagasic Cardiopathy (STCC): study protocol for a double-blind randomized controlled trial

BACKGROUND: Heart disease progression occurs in 30% of patients with chronic Trypanosoma cruzi infection. Supplementation with selenium (Se) in animal model of T. cruzi infection produced promising results. There is evidence that patients with Chagas heart disease have lower Se levels than healthy i...

Descripción completa

Detalles Bibliográficos
Autores principales:	Alvarenga Americano do Brasil, Pedro Emmanuel, Pereira de Souza, Andréa, Hasslocher-Moreno, Alejandro Marcel, Xavier, Sérgio Salles, Lambert Passos, Sonia Regina, de Fátima Ramos Moreira, Maria, Santini de Oliveira, Marília, Sperandio da Silva, Gilberto Marcelo, Magalhães Saraiva, Roberto, Santos de Aguiar Cardoso, Claudia, de Sousa, Andréa Silvestre, Mediano, Mauro Felippe Felix, Bonecini de Almeida, Maria da Gloria, da Cruz Moreira, Otacílio, Britto, Constança, de Araújo-Jorge, Tania Cremonini
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2014
Materias:	Study Protocol
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4197263/ https://www.ncbi.nlm.nih.gov/pubmed/25284194 http://dx.doi.org/10.1186/1745-6215-15-388

Ejemplares similares

A protocol update for the Selenium Treatment and Chagasic Cardiomyopathy (STCC) trial
por: Holanda, Marcelo Teixeira, et al.
Publicado: (2018)

Effects of Selenium treatment on cardiac function in Chagas heart disease: Results from the STCC randomized Trial
por: Holanda, Marcelo T., et al.
Publicado: (2021)

Role of FAK signaling in chagasic cardiac hypertrophy
por: Tucci, Amanda R., et al.
Publicado: (2020)

Progression Rate from the Indeterminate Form to the Cardiac Form in Patients with Chronic Chagas Disease: Twenty-Two-Year Follow-Up in a Brazilian Urban Cohort
por: Hasslocher-Moreno, Alejandro Marcel, et al.
Publicado: (2020)

Discussing the Score of Cardioembolic Ischemic Stroke in Chagas Disease
por: Mendes, Fernanda de Souza Nogueira Sardinha, et al.
Publicado: (2020)

Omega-3 supplementation on inflammatory markers in patients with chronic Chagas cardiomyopathy: a randomized clinical study
por: Silva, Paula Simplício da, et al.
Publicado: (2017)

Pentoxifylline Reverses Chronic Experimental Chagasic Cardiomyopathy in Association with Repositioning of Abnormal CD8(+) T-Cell Response
por: Pereira, Isabela Resende, et al.
Publicado: (2015)

Effects of Cholinergic Stimulation with Pyridostigmine Bromide on Chronic Chagasic Cardiomyopathic Mice
por: de Cuba, Marília Beatriz, et al.
Publicado: (2014)

Stroke Correlates in Chagasic and Non-Chagasic Cardiomyopathies
por: da Matta, José Alberto Martins, et al.
Publicado: (2012)

Temporal changes in the clinical-epidemiological profile of patients with Chagas disease at a referral center in Brazil
por: Hasslocher-Moreno, Alejandro Marcel, et al.
Publicado: (2021)

Selenium, TGF-Beta and Infectious Endemic Cardiopathy: Lessons from Benchwork to Clinical Application in Chagas Disease
por: Araujo-Jorge, Tania C., et al.
Publicado: (2022)

Exploring the parasite load and molecular diversity of Trypanosoma cruzi in patients with chronic Chagas disease from different regions of Brazil
por: Rodrigues-dos-Santos, Ícaro, et al.
Publicado: (2018)

Effects of omega-3 polyunsaturated fatty acid supplementation in patients with chronic chagasic cardiomyopathy: study protocol for a randomized controlled trial
por: Silva, Paula S, et al.
Publicado: (2013)

Sympathetic Dysautonomia in Heart Failure by (123)I-MIBG: comparison between Chagasic, non-Chagasic and heart transplant patients
por: Marino, Viviane Santuari Parisotto, et al.
Publicado: (2018)

Chagas disease mortality during the coronavirus disease 2019 pandemic: A Brazilian referral center experience
por: Hasslocher-Moreno, Alejandro Marcel, et al.
Publicado: (2022)

FIRST REPORT OF ACUTE CHAGAS DISEASE BY VECTOR TRANSMISSION IN RIO DE JANEIRO STATE, BRAZIL
por: SANGENIS, Luiz Henrique Conde, et al.
Publicado: (2015)

Validation of the NAT Chagas IVD Kit for the Detection and Quantification of Trypanosoma cruzi in Blood Samples of Patients with Chagas Disease
por: Moreira, Otacilio C., et al.
Publicado: (2023)

The association between variables of cardiopulmonary exercise test and quality of life in patients with chronic Chagas cardiomyopathy (Insights from the PEACH STUDY)
por: Vieira, Marcelo Carvalho, et al.
Publicado: (2022)

Sports Events and Acute Coronary Syndrome: Possible Confounding Factors and Bias
por: Mediano, Mauro Felippe Felix, et al.
Publicado: (2013)

Clinical Course After Cardioverter-Defibrillator Implantation: Chagasic Versus Ischemic Patients
por: Pereira, Francisca Tatiana Moreira, et al.
Publicado: (2016)

Combination Chemotherapy with Suboptimal Doses of Benznidazole and Pentoxifylline Sustains Partial Reversion of Experimental Chagas' Heart Disease
por: Vilar-Pereira, Glaucia, et al.
Publicado: (2016)

Prevalence of metabolic syndrome and associated factors among patients with chronic Chagas disease
por: Xavier, Isis Gabrielli Gomes, et al.
Publicado: (2021)

Chagasic megacolon: enteric neurons and related structures
por: Jabari, Samir, et al.
Publicado: (2014)

Prognostic Factors in Severe Chagasic Heart Failure
por: Costa, Sandra de Araújo, et al.
Publicado: (2017)

Inducible Nitric Oxide Synthase in Heart Tissue and Nitric Oxide in Serum of Trypanosoma cruzi-Infected Rhesus Monkeys: Association with Heart Injury
por: Carvalho, Cristiano Marcelo Espinola, et al.
Publicado: (2012)

Therapy with Cardiomyocytes Derived from Pluripotent Cells in Chronic Chagasic Cardiomyopathy
por: Brasil, Guilherme Visconde, et al.
Publicado: (2020)

Evolution of anti-Trypanosoma cruzi antibody production in patients with chronic Chagas disease: Correlation between antibody titers and development of cardiac disease severity
por: Georg, Ingebourg, et al.
Publicado: (2017)

Partial, selective survival of nitrergic neurons in chagasic megacolon
por: Jabari, Samir, et al.
Publicado: (2010)

Effect of physical exercise training in patients with Chagas heart disease: study protocol for a randomized controlled trial (PEACH study)
por: Mendes, Fernanda de Souza Nogueira Sardinha, et al.
Publicado: (2016)

Epidemiological-clinical profile and mortality in patients coinfected with Trypanosoma cruzi/HIV: experience from a Brazilian reference center
por: Hasslocher-Moreno, Alejandro Marcel, et al.
Publicado: (2022)

Comprehensive care for patients with Chagas cardiomyopathy during the coronavirus disease pandemic
por: Mazzoli-Rocha, Flavia, et al.
Publicado: (2020)

Left Atrial Function in Patients with Chronic Chagasic Cardiomyopathy
por: Fragata, Claudia da Silva, et al.
Publicado: (2015)

Commercial enzyme-linked immunosorbent assay versus polymerase chain reaction for the diagnosis of chronic Chagas disease: a systematic review and meta-analysis
por: do Brasil, Pedro Emmanuel Alvarenga Americano, et al.
Publicado: (2016)

Atrial cardiopathy and stroke
por: Elkind, Mitchell S. V.
Publicado: (2022)

Stem Cell-Based Therapies in Chagasic Cardiomyopathy
por: Campos de Carvalho, Antonio Carlos, et al.
Publicado: (2015)

Bone marrow cell migration to the heart in a chimeric mouse model of acute chagasic disease
por: Irion, Camila Iansen, et al.
Publicado: (2017)

Association between Trypanosoma cruzi DTU TcII and chronic Chagas disease clinical presentation and outcome in an urban cohort in Brazil
por: Nielebock, Marco Antonio Prates, et al.
Publicado: (2020)

Electrophysiological study in chagasics with syncope and conduction disorder
por: Dreicon, Alexia Hallack, et al.
Publicado: (2023)

Prediction Models for Decision-Making on Chagas Disease
por: Mendes, Fernanda de Souza Nogueira Sardinha, et al.
Publicado: (2017)

Adverse drug events and the associated factors in patients with chronic Chagas disease
por: Lopes, Luiza Braz da Cunha, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_u51qfrinlgjsh2p8ook6rlm0o4